Jay West is Principal Scientist at Bristol Myers Squibb in the Process Development Analytics group in Devens, MA. Jay received his BS in Chemistry from Rensselaer, MS in Chemistry from University of Albany and worked at Regeneron Pharmaceuticals for 2.5 years. Jay received PhD in Biochemistry from Boston College and performed postdoctoral research at Northeastern University. He started at BMS in 2014 as an analytical scientist. His focus for the past five years has been on Process Analytical Technology, particularly on applications for downstream biologics process development.

Renata Pocitarenco is an Associate Scientist at Janssen, Switzerland. She received a B.Sc. and a M.Sc. in Chemical and Process Engineering from University of Padova, Italy, in 2019 and 2021 respectively, focusing on process systems engineering, chemometrics and statistical modeling. During her M.Sc. she spent 3 semesters abroad, doing an Erasmus at Otto Von Guericke Universität, Germany, an internship at Toyota Motor Europe, Belgium, and an internship at Janssen focusing on Machine Learning and simulations. She is passionate about mechanistic and data-driven modeling as tools to enhance and optimize pharmaceutical industrial processes.

Marius Müller is leading the analytical fill-finish support team at Janssen, Schaffhausen, Switzerland. His team is responsible for analytical study support as well as scouting, development and implementation of new PAT tools for drug product manufacturing. Marius joined Janssen as postdoc in 2018, establishing new analytical technologies for protein stability and aggregation. He holds a PhD in the field of mammalian synthetic biology and metabolic engineering from ETH Zürich in Switzerland. Prior he received his MSc degree in medical sciences from the University of Strasbourg in France as part of a tri-national study program.

Aishwarya Ramanan is part of the Seagen Purification BioProcess Development Group and focuses her efforts on process analytical technology (PAT) strategy evaluation and process intensification implementation for the downstream purification process. She received her Master's in Bio-Pharmaceutical Engineering & Biotechnology from University of Pennsylvania and has over 8 years of experience specializing in downstream process development. She continues to drive innovation and optimization to the purification process.

Ralf Kuriyel joined Repligen in October 2016 as the Senior Vice President, Research and Development where he oversees the Company’s R&D efforts. Mr. Kuriyel was previously Vice President of Applications for the single-use business unit within the Life Sciences division of Pall Corporation (“Pall”), whose acquisition by Danaher Corporation was completed in August 2015. At Pall, Mr. Kuriyel served as Vice President of R&D, Field Applications and Process Development Services from November 2014 to October 2016. In addition, Mr. Kuriyel served as Vice President, Applications R&D at Pall from November 2011 to November 2014. Mr. Kuriyel received a B.S. and an M.S. in Chemical Engineering from Rensselaer Polytechnic Institute and has completed his coursework for the Tufts University Ph.D. program in Chemical Engineering. He is an inventor of multiple patents and has co-authored over 30 scientific publications on bioprocessing, including separations technologies, membrane separations methods, protein processing and enhanced microfiltration techniques.